Development and validation of a predictive model to guide the use of plerixafor in pediatric population - Poll - MDSpire

Development and validation of a predictive model to guide the use of plerixafor in pediatric population

  • By

  • Bernard Sebastien

  • Peter Cheverton

  • Catherine Magnin

  • Jihane Aouni

  • Remi Castan

  • September 26, 2022

  • 0 min

Share

Original Source(s)

Development and validation of a predictive model to guide the use of plerixafor in pediatric population

  • by Bernard Sebastien, Peter Cheverton, Catherine Magnin, Jihane Aouni, Remi Castan

  • September 26, 2022

Related Content

Prevalence and Contributing Factors of Hypothyroidism in Hematological Malignancy Patients Compared to Healthy Individuals: A Systematic Review and Meta-Analysis

Prognostic impact of organ involvement in aggressive adult T-cell leukemia/lymphoma: definition of risk organ and proposal of a prognostic index

Analysis of the Frequency and Outcomes of Transformed Nodular Lymphocyte-Predominant Hodgkin Lymphoma in the United States: A Population-Based Study